Receipt of Section 249D Notice from BCAL Diagnostics

Key points

• Genetic Signatures Ltd received a Section 249D Notice from BCAL Diagnostics
• Notice requests removal of Jenny Harry as a director
• Company is considering the notice and will comply if valid

Full summary

Genetic Signatures Limited (ASX: GSS) has received a request from BCAL Diagnostics Limited pursuant to section 249D of the Corporations Act for the directors of GSS to call and arrange a general meeting of shareholders for the purposes of considering the removal of Jenny Harry as a director. GSS is currently considering the section 249D notice and will comply with its relevant obligations under the Corporations Act if it deems the notice to be valid. The company will then undertake the necessary steps to convene a general meeting.

Outlook

Genetic Signatures Ltd is currently evaluating the notice and will take appropriate action if it finds the request to be valid.